𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Lithium use in octogenarians

✍ Scribed by Sabina Fahy; Brian A. Lawlor


Publisher
John Wiley and Sons
Year
2001
Tongue
English
Weight
50 KB
Volume
16
Category
Article
ISSN
0885-6230

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Objectives

To assess the tolerability and side‐effect profile of lithium use in a group of octogenarians attending a specialized lithium clinic.

Methods

This is a cross‐sectional study looking at all patients of eighty years and over attending a lithium clinic. Charts were examined to assess renal function, thyroid function and level of side‐effects during their course of lithium treatment in order to assess the tolerability of this medication in octogenarians.

Results

Twelve patients of 80 years and over (with an average age of 83.6 years) were taking lithium for an average period of 53.7 months. They had a mean serum level of 0.42 mmol/l. No patient had to discontinue lithium therapy because of side‐effects, even though some patients did develop transient abnormalities of renal function. One patient developed diabetes insipidus. One female patient developed hypothyroidism.

Conclusions

Lithium was well tolerated and was administered safely to this cohort of octogenarians. Monitoring of serum lithium levels and kidney and thyroid function should preferably be done in the setting of a specialized lithium clinic. Copyright Β© 2001 John Wiley & Sons, Ltd.


πŸ“œ SIMILAR VOLUMES


Breast cancer in octogenarians
✍ Ella Evron; Hadassah Goldberg; Alexander Kuzmin; Roee Gutman; Shulamith Rizel; A πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 112 KB
An open study of buspirone in octogenari
✍ Sidney Levine; Michael J. Napoliello; Antonio G. Domantay πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 English βš– 221 KB

In this study buspirone demonstrated efficacy and safety in the treatment of anxiety in elderly patients age 80 years or older. The results are consistent with data from earlier clinical and pharmacokinetic studies in elderly patients 60 years and older.